Age-Related Vision Dysfunction Insights and Trends

• Age-related retinal disorders, particularly AMD, are a leading cause of vision impairment and blindness worldwide, with prevalence expected to rise significantly due to population aging and increased life expectancy.
• Among different forms of age-related retinal dysfunction, dry AMD accounts for the majority of diagnosed cases, while wet AMD contributes disproportionately to severe vision loss due to rapid disease progression and retinal neovascularization.
• The growing adoption of advanced retinal imaging technologies such as OCT and AI-assisted screening is improving early diagnosis and expanding the detectable patient pool, although a significant proportion of early-stage retinal disease remains undiagnosed or undertreated, particularly in regions with limited access to specialized eye care.
• Developed regions such as the United States, EU4, the UK, and Japan continue to account for the largest diagnosed patient pools due to stronger healthcare infrastructure, higher screening penetration, and greater awareness of retinal diseases.
• Increasing awareness regarding age-related ocular disorders and rising utilization of preventive ophthalmology programs are expected to support earlier intervention and improved long-term visual outcomes across the 7MM.

Age-Related Vision Dysfunction Epidemiology Forecast in the United States

• 2025 Prevalent Cases of Age-Related Vision Dysfunction: ~XXXX
• 2036 Projected Prevalent Cases of Age-Related Vision Dysfunction:  XXXX
• Age-Related Vision Dysfunction Growth Rate (2026–2036): XX% CAGR

DelveInsight's ‘Age-Related Vision DysfunctionEpidemiology Forecast – 2036’ report delivers an in-depth understanding of the Age-Related Vision Dysfunction, historical and forecasted epidemiology in the United States, EU4 (Germany, Spain, Italy, and France), and the United Kingdom, and Japan.

Age-Related Vision Dysfunction Understanding

Age-Related Vision Dysfunction Overview

Age-related vision dysfunction is a progressive ocular condition marked by a gradual decline in visual function with aging, leading to reduced visual acuity, contrast sensitivity, dark adaptation, and overall vision quality. It includes a range of age-associated disorders such as presbyopia, cataracts, AMD, diabetic retinopathy, glaucoma, and other retinal or optic nerve diseases that contribute to functional vision loss in older adults. The condition affects central and peripheral vision, depth perception, and low-light performance, significantly impacting daily activities such as reading, driving, mobility, and facial recognition.

The condition arises from cumulative structural and physiological changes in ocular tissues, including lens stiffening, retinal degeneration, oxidative stress, mitochondrial dysfunction, vascular impairment, and progressive loss of photoreceptor and retinal pigment epithelial function. Risk factors such as advanced age, diabetes, smoking, hypertension, obesity, genetic predisposition, and prolonged ultraviolet exposure further accelerate disease progression. If left untreated or poorly managed, age-related vision dysfunction can result in significant visual disability, increased risk of falls, loss of independence, and reduced quality of life in older adults.

Age-Related Vision Dysfunction Diagnosis

Diagnosis of age-related vision dysfunction involves a comprehensive ophthalmic evaluation to identify the cause and extent of visual impairment. It typically includes patient history, symptom assessment, visual acuity testing, refraction, contrast sensitivity evaluation, and visual field examination. Additional tools such as slit-lamp examination, fundoscopy, intraocular pressure measurement, optical coherence tomography (OCT), fluorescein angiography, retinal imaging, and dark adaptation testing help assess retinal, lens, optic nerve, and vascular changes associated with age-related ocular disorders.

The diagnostic approach varies by condition, including cataracts, AMD, glaucoma, diabetic retinopathy, and other retinal degenerations. Early detection through routine eye exams is essential, as many conditions progress slowly and remain asymptomatic in early stages. Timely diagnosis enables earlier intervention, better disease management, and preservation of long-term visual function and quality of life.

Further details are provided in the report.

Age-Related Vision Dysfunction Epidemiology

Key Findings from Age-Related Vision Dysfunction Epidemiological Analysis and Forecast 

• Age-related vision dysfunction is a major global public health concern, with prevalence increasing significantly with age. It rises sharply after 60 and becomes even more common and severe after 75.
• Female patients account for a higher proportion of the affected population, largely due to longer life expectancy and greater age-related disease burden compared with males. 
• The epidemiological burden of diabetic retinal disorders and wet AMD is expected to increase steadily during the forecast period, supported by rising diabetes prevalence, increasing smoking rates, obesity, and other retinal degeneration risk factors. 
• As per DelveInsight estimates, presbyopia accounted for the highest prevalent patient population among all considered age-related vision dysfunction etiologies across the 7MM. 
• The United States accounted for more than 35% of wet AMD cases and represented the highest prevalent glaucoma population within the 7MM in 2025, primarily due to high diagnosis rates and a large aging population. 
• Japan accounted for nearly 50% of the total diagnosed prevalent cases of presbyopia in 2025, reflecting the country’s large elderly demographic and high healthcare screening penetration.

Scope of the Report

• The report covers a segment of an executive summary, a descriptive overview of Age-Related Vision Dysfunction, explaining its causes, signs and symptoms, and pathogenesis.
• Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression.

Report Insights

Age-Related Vision Dysfunction Patient Population Forecast

Report Key Strengths

• Epidemiology‑based (epi‑based) Bottom‑up Forecasting
• 11-year Forecast 
• Patient Burden Trends (by geography)

FAQs

• What are the disease risks, burdens, and unmet needs of Age-Related Vision Dysfunction? What will be the growth opportunities across the 7MM concerning the patient population with Age-Related Vision Dysfunction?
• What is the historical and forecasted Age-Related Vision Dysfunction patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?

Reasons to Buy

• Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
• To understand key opinion leaders’ perspectives on the diagnostic challenges to overcome barriers in the future.
• Detailed insights into various factors hampering disease diagnosis and other existing diagnostic challenges.